ERASCA INC's ticker is and the CUSIP is 29479A108. A total of 118 filers reported holding ERASCA INC in Q1 2023. The put-call ratio across all filers is 4.86 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $118,826 | -77.9% | 43,053 | -75.9% | 0.00% | -100.0% |
| Q1 2023 | $537,938 | +123.4% | 178,717 | +219.9% | 0.00% | +100.0% |
| Q4 2022 | $240,808 | -0.9% | 55,872 | +79.5% | 0.00% | 0.0% |
| Q3 2022 | $243,000 | +59.9% | 31,126 | +13.9% | 0.00% | – |
| Q2 2022 | $152,000 | -34.5% | 27,332 | +1.2% | 0.00% | – |
| Q1 2022 | $232,000 | -44.9% | 27,000 | 0.0% | 0.00% | -100.0% |
| Q4 2021 | $421,000 | – | 27,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AH Equity Partners Bio II, L.L.C. | 2,500,000 | $19,500,000 | 13.59% |
| ARCH Venture Management, LLC | 11,055,554 | $86,233,000 | 11.18% |
| EDBI Pte Ltd | 888,888 | $6,933,000 | 7.30% |
| Cormorant Asset Management, LP | 10,505,554 | $81,943,000 | 5.73% |
| AH Equity Partners V, L.L.C. | 50,000 | $390,000 | 2.53% |
| AH Equity Partners LSV II, L.L.C. | 312,500 | $2,438,000 | 2.18% |
| PFM Health Sciences, LP | 7,264,981 | $56,667,000 | 2.05% |
| Artal Group S.A. | 3,172,221 | $24,743,000 | 1.06% |
| REGENTS OF THE UNIVERSITY OF CALIFORNIA | 472,472 | $3,685,000 | 0.75% |
| EcoR1 Capital, LLC | 678,441 | $5,292,000 | 0.16% |